Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > CD8+ TiLs and T-cell exhaustion

<< Previous

Bullboard Posts

Next >>

Comment by venture009on Aug 13, 2024 9:38am

41 Views

Post# 36176288

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustion

Of course it is . You missed the point. It creates more and more debt and eventually you can't pay even the carrying costs . The US is a few years away from this occurrence. In the mean time everyone's standard of living declines and dopes keeping wanting the government to do more. If you're one of those then like so many you haven't learned much. Freedom is being erased by progressive parties. Look at the recent incidents in Great Britain. Look at Tulsi Gabbard. They want control of everything. You'll own nothing and be happy.

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024